BBVA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BBVA is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who wants to act now rather than wait. The business fundamentals are improving, but the current technical setup is neutral to slightly weak, analyst sentiment has recently softened, and the latest proprietary signals show no buy trigger. My direct view: hold for now, not buy today.
BBVA is trading at 21.83, slightly below the previous close of 21.87, with the regular session down 1.31%. The RSI_6 at 49.81 is neutral, showing no momentum edge. MACD histogram is -0.0732, below zero but contracting, which suggests bearish pressure is easing rather than accelerating. Moving averages are converging, indicating a lack of trend conviction. Key levels show pivot at 21.621, resistance at 22.276/22.681, and support at 20.966/20.561. Overall, the chart is range-bound and not offering a clean entry signal. The pattern-based estimate also points to a 60% chance of -3.05% next day, which is weak for an immediate buy.
Latest quarter financials were solid in 2025/Q4: revenue grew 11.72% YoY, net income rose 14.02% YoY, and EPS increased 16.28% YoY. That shows healthy underlying business momentum. Analyst JPMorgan remains Overweight with a raised target of EUR 23.60, which still supports upside potential. There has been no recent news, so there are no fresh negative event shocks. Hedge funds and insiders are neutral, which avoids a bearish ownership signal.
Recent analyst tone has weakened: Oddo BHF downgraded BBVA to Neutral and UBS downgraded it to Neutral, with UBS also lowering its target to EUR 20.50 due to harder-to-come-by Turkey catalysts amid Middle East conflict. No recent news means no immediate positive catalyst to re-rate the stock. Technical momentum is weak, and the short-term pattern outlook suggests downside risk next day. There is no AI Stock Picker or SwingMax buy signal today. No recent congress trading data and no notable politician/influencer buying support the stock.
In 2025/Q4, BBVA posted strong year-over-year growth: revenue increased to 12.10B, up 11.72%; net income rose to 2.83B, up 14.02%; and EPS reached 0.50, up 16.28%. This is a healthy latest-quarter season showing earnings and revenue growth remain intact. The gross margin data is not meaningful for a bank, so the key takeaways are revenue, net income, and EPS growth, all of which were positive.
Analyst sentiment is mixed to slightly cautious. Positive: JPMorgan kept Overweight and lifted its target to EUR 23.60, and Deutsche Bank raised its target to EUR 21.24 with a Buy rating. Negative: UBS downgraded to Neutral and cut target to EUR 20.50, citing weaker Turkey-related catalysts; Oddo BHF also downgraded to Neutral with a EUR 22 target. Overall, Wall Street is divided, but the recent direction has become more conservative, so the pros view is no longer strongly bullish.
